OncoCyte Corp (NASDAQ:OCX)

Delayed Data
As of Sep 27
 -0.0464 / -5.81%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for OncoCyte Corp have a median target of 2.30, with a high estimate of 4.00 and a low estimate of 1.15. The median estimate represents a +205.81% increase from the last price of 0.75.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in OncoCyte Corp. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -55.10%
Growthannually 45.44%


Growthquarterly -27.91%
Growthannually -8.95%
Key to the earnings and sales forecast charts.